ASH Clinical News ACN_4.14_Full Issue_web | Page 156

Medical Mistakes Continued from page 152 of the WHO’s 19-item Surgical Safety Checklist in eight hospitals in eight countries representing a variety of economic circumstances. 15 Adherence to these checklists decreased the rates of adverse events, surgical mortality, surgical-site infection, and unplanned reoperation, compared with the period before the checklists were implemented. Despite its ability to improve outcomes, the WHO checklist is only a partial solution, albeit one that is widely used in operating rooms across the world. Making a dent in preventable medical errors will require successful implementation of safety checklists at a large scale and buy-in from all stake- holders, including hospital CEOs. 16 Practice guidelines and protocols are another way to reduce practice variation and prevent errors. In addition to aiding memory, they also serve to set performance standards and expectations for health- care professionals. “We have not come up with reliable systems for communicating key data across institutions, and I think it’s possible that this can put patients at risk.” —JOSEPH JACOBSON, MD, MSc ASH’s Committee on Quality is focused on develop- ing evidence-based practice guidelines for several areas of hematology practice. ASH just released the first six of 10 clinical practice guidelines on venous throm- boembolism in late November, and future efforts will cover immune thrombocytopenia, sickle cell disease, leukemia in older patients, and von Willebrand disease. Reducing excessive resource use, experts contend, re- duces the opportunity for preventable medical mistakes, like medication errors or unnecessary transfusions. “On the Committee on Quality, we are trying to develop evidence-based guidelines, which is one way to try to disseminate best practices, decrease practice variation, and ultimately improve safety by ensuring that there’s high-quality guidance available for physi- cians,” she told ASH Clinical News. Dr. Hicks also chairs the Choosing Wisely Task Force for ASH. Choosing Wisely is a medical stewardship initiative led by the American Board of Internal Medicine Foundation in collaboration with U.S. professional medical societies. In 2013 and 2014, Dr. Hicks and her team identified 10 hema- tologic tests and treatments that hematologists and their patients should question ( SIDEBAR 2 ). 17,18 “When we start to view things through the lens of overuse, we’ll find examples in every field, just like there are examples of medical error in every field,” she said. 154 ASH Clinical News A New Era of Patient Safety “To err is human, but errors can be prevented,” wrote the authors of the IOM report in 1999. In the almost 20 years since publication of this transformative report, progress – albeit variable and inconsistent – has been made to do just that, authors wrote in an editorial summarizing the past two decades of the patient safety movement. 19 New approaches are needed to address both prior and emerging areas of risk. The next chal- lenge will likely by to find tools that allow organizations to “measure any reduction of harm both inside and outside the hospital, continuously and routinely.” If the time since the IOM report might be considered the Bronze Age of patient safety, when “primitive” tools were developed to begin measuring and managing patient error, the next decade prom- ises to be the Golden Age, where “vast improvement in patient safety” is realized, they concluded. —By Debra L. Beck ● REFERENCES 1. SIDEBAR 2 American Society of Hematology presents TEN THINGS PHYSICIANS AND PATIENTS SHOULD QUESTION 1 Don’t transfuse more than the minimum number of red blood cell (RBC) units necessary to relieve symptoms of anemia or to return a patient to a safe hemoglobin range (7 to 8 g/dL in stable, non-cardiac in-patients). 2 Don’t test for thrombophilia in adult patients with venous thromboembolism (VTE) occurring in the setting of major transient risk factors (surgery, trauma or prolonged immobility). 3 Don’t use inferior vena cava (IVC) filters routinely in patients with acute VTE. 4 Don’t administer plasma or prothrombin complex concentrates for non-emergent reversal of vitamin K antagonists (i.e. outside of the setting of major bleeding, intracranial hemorrhage or anticipated emergent surgery). 5 Limit surveillance computed tomography (CT) scans in asymptomatic patients following curative-intent treatment for aggressive lymphoma. 6 Don’t treat with an anticoagulant for more than three months in a patient with a first venous thromboembolism (VTE) occurring in the setting of a major transient risk factor. 7 Don’t routinely transfuse patients with sickle cell disease (SCD) for chronic anemia or uncomplicated pain crisis without an appropriate clinical indication. 8 Don’t perform baseline or routine surveillance computed tomography (CT) scans in patients with asymptomatic, early- stage chronic lymphocytic leukemia (CLL). 9 Don’t test or treat for suspected heparin- induced thrombocytopenia (HIT) in patients with a low pre-test probability of HIT. HHS.gov. Opioid crisis statistics. Accessed October 29, 2018, from https://www.hhs.gov/opioids/about-the-epidemic/index.html. 2. Makary MA, Daniel M. Medical error—the third leading cause of death in the US. BMJ. 2016;353:i2139. 3. Kohn LT, Corrigan JM, Donaldson MS, editors. To err is human: building a safer health system. Washington (DC): National Academies Press (US); 2000. 4. James JT. A new, evidence-based estimate of patient harms associated with hospital care. J Patient Saf. 2013;9:122-8. 5. Gilligan T. Trespass and forgiveness. Cura. Accessed November 9, 2018, from https://cura.space/2018/09/16/trespass-and- forgiveness/. 6. Waterman AD, Garbutt J, Hazel E, et al. The emotional impact of medical errors on practicing physicians in the United States and Canada. Jt Comm J Qual Patient Saf. 2007;33:467-76. 7. Collaborative for Accountability and Improvement. Communication & resolution programs. Accessed October 29, 2018, from http:// communicationandresolution.org/communication-and-resolution- programs/. 8. Gallagher TH, Mello MM, Sage WM, et al. Can communication-and- resolution programs achieve their potential? Five key questions. Health Aff (Millwood). 2018;37:1845-52. 9. Kachalia A, Sands K, Van Niel M, et al. Effects of a communication- and-resolution program on hospitals’ malpractice claims and costs. Health Aff (Millwood). 2018;37:1836-44. 10. AHRQ. Communication and Optimal Resolution (CANDOR) Toolkit. Accessed October 29, 2018, from https://www.ahrq.gov/ professionals/quality-patient-safety/patient-safety-resources/ resources/candor/introduction.html. 11. Dossett LA, Kauffmann RM, Lee JS, et al. Specialist physicians’ attitudes and practice patterns regarding disclosure of pre-referral medical errors. Ann Surg. 2018;267:1077-83. 12. Dossett LA, Kauffmann RM, Miller J, et al. The challenges of providing feedback to referring physicians after discovering their medical errors. J Surg Res. 2018;232:209-16. 13. Ratwani RM, Savage E, Will A, et al. Identifying electronic health record usability and safety challenges in pediatric settings. Health Aff (Millwood). 2018;37:1752-9. 14. Classen D, Li M, Miller S, Ladner D. An electronic health record-based real-time analytics program for patient safety surveillance and improvement. Health Aff (Millwood). 2018;37:1805-12. 15. Haynes AB, Weiser TG, Berry WR, et al. A surgical safety checklist to reduce morbidity and mortality in a global population. N Engl J Med. 2009;360:491-9. 16. Berry WR, Edmondson L, Gibbons LR, et al. Scaling safety: the South Carolina surgical safety checklist experience. Health Aff (Millwood). 2018;37:1779-86. 17. Hicks LK, Bering H, Carson KR, et al. The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question. Blood. 2013; 122:3879-83. 18. Hicks LK, Bering H, Carson KR, et al. Five hematologic tests and treatments to question. Blood. 2014;124:3524-8. 19. Bates DW, Singh H. Two decades since To Err is Human: An assessment of progress and emerging priorities in patients Safety. Health Aff (Millwood). 2018;37:1736-43. 10 Don’t treat patients with immune thrombo- cytopenic purpura (ITP) in the absence of bleeding or a very low platelet count. December 2018